Morrison Responds

Editor's Note: Following is Adrian Morrison's response to Marc Bekoff's letter. Marc Bekoff would have liked me to focus on something other than the very real distortions in Animal Liberation, which are amply (but not exhaustively) treated by Sharon M. Russell and Charles S. Nicoll's paper (Proceedings of the Society for Experimental Biology and Medicine, 211-2:109-38, 1996, with a rebuttal by Singer on pp. 139-46 and their reply to his rebuttal on pp. 147-54). Singer's attack is really on all

Written byAdrian Morrison
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Editor's Note: Following is Adrian Morrison's response to Marc Bekoff's letter.

Marc Bekoff would have liked me to focus on something other than the very real distortions in Animal Liberation, which are amply (but not exhaustively) treated by Sharon M. Russell and Charles S. Nicoll's paper (Proceedings of the Society for Experimental Biology and Medicine, 211-2:109-38, 1996, with a rebuttal by Singer on pp. 139-46 and their reply to his rebuttal on pp. 147-54). Singer's attack is really on all invasive animal research, not some research, as Bekoff would have one believe. Unfortunately, Singer and his disciples are unwilling to acknowledge that those of us who believe it necessary and appropriate to use animals for the benefit of their fellow humans do so guided not only by their own ethical standards but also by governmental regulation. That process involves personal evaluation of the worth of a proposed experiment and careful ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies